Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells

Journal of Neuroimmunology

Volumn 250, Issue 1-2, 2012, Pages 99-105

  Aung, Latt Latt ^a   Brooks, Andrew ^a   Greenberg, Steven A ^b   Rosenberg, Michael L ^c   Dhib Jalbut, Suhayl ^a   Balashov, Konstantin E ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c New Jersey Neuroscience Institute   (United States)

Author keywords

Biomarkers; Gene expression; Interferon beta; Multiple sclerosis; Plasmacytoid dendritic cells

Indexed keywords

BETA1A INTERFERON; BIOLOGICAL MARKER; INTERFERON BETA SERINE;

ADULT; ARTICLE; ASSAY; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

ADULT; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864851464     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.05.013     Document Type: Article

References (69)

1. Arnason B.G., Dayal A., Qu Z.X., Jensen M.A., Genc K., Reder A.T. Mechanisms of action of interferon-beta in multiple sclerosis. Springer Semin. Immunopathol. 1996, 18:125-148.
2. Arnett H.A., Escobar S.S., Gonzalez-Suarez E., Budelsky A.L., Steffen L.A., Boiani N., Zhang M., Siu G., Brewer A.W., Viney J.L. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 2007, 178:1523-1533.
3. Aung L.L., Fitzgerald-Bocarsly P., Dhib-Jalbut S., Balashov K. Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta. J. Neuroimmunol. 2010, 226:158-164.
4. Balashov K.E., Aung L.L., Vaknin-Dembinsky A., Dhib-Jalbut S., Weiner H.L. Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis. Ann. Neurol. 2010, 68:899-906.
5. Baranzini S.E., Elfstrom C., Chang S.Y., Butunoi C., Murray R., Higuchi R., Oksenberg J.R. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol. 2000, 165:6576-6582.
6. Barrios-Rodiles M., Brown K.R., Ozdamar B., Bose R., Liu Z., Donovan R.S., Shinjo F., Liu Y., Dembowy J., Taylor I.W., Luga V., Przulj N., Robinson M., Suzuki H., Hayashizaki Y., Jurisica I., Wrana J.L. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005, 307:1621-1625.
7. Bomprezzi R., Ringner M., Kim S., Bittner M.L., Khan J., Chen Y., Elkahloun A., Yu A., Bielekova B., Meltzer P.S., Martin R., McFarland H.F., Trent J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 2003, 12:2191-2199.
8. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000, 1:305-310.
9. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., Mounzer K., Kostman J., Trinchieri G., Montaner L.J. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 2002, 168:4796-4801.
10. Chen H., Ishii A., Wong W.K., Chen L.B., Lo S.H. Molecular characterization of human tensin. Biochem. J. 2000, 351(Pt 2):403-411.
11. Chen H., Duncan I.C., Bozorgchami H., Lo S.H. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:733-738.
12. Chen Y., Miller C., Mosher R., Zhao X., Deeds J., Morrissey M., Bryant B., Yang D., Meyer R., Cronin F., Gostout B.S., Smith-Mccune K., Schlegel R. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res. 2003, 63:1927-1935.
13. Curtin J.F., King G.D., Barcia C., Liu C., Hubert F.X., Guillonneau C., Josien R., Anegon I., Lowenstein P.R., Castro M.G. Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain. J. Immunol. 2006, 176:3566-3577.
14. Dutta R., McDonough J., Chang A., Swamy L., Siu A., Kidd G.J., Rudick R., Mirnics K., Trapp B.D. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 2007, 130:2566-2576.
15. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 2001, 159:237-243.
16. Feldman S., Stein D., Amrute S., Denny T., Garcia Z., Kloser P., Sun Y., Megjugorac N., Fitzgerald-Bocarsly P. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 2001, 101:201-210.
17. Gandhi K.S., McKay F.C., Cox M., Riveros C., Armstrong N., Heard R.N., Vucic S., Williams D.W., Stankovich J., Brown M., Danoy P., Stewart G.J., Broadley S., Moscato P., Lechner-Scott J., Scott R.J., Booth D.R. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet. 2010, 19:2134-2143.
18. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002, 195:695-704.
19. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005, 11:328-334.
20. Haahr S., Hollsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev. Med. Virol. 2006, 16:297-310.
21. Hovanessian A.G. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. J. Interferon Res. 1991, 11:199-205.
22. Huang Y.M., Kouwenhoven M., Jin Y.P., Press R., Huang W.X., Link H. Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression. Mult. Scler. 2001, 7:95-99.
23. Jirmanova L., Jankovic D., Fornace A.J., Ashwell J.D. Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation. J. Immunol. 2007, 178:4153-4158.
24. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38:D355-D360.
25. Kang J.H., Sheu J.J., Kao S., Lin H.C. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J. Infect. Dis. 2011, 204:188-192.
26. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
27. Kuwana M., Kaburaki J., Wright T.M., Kawakami Y., Ikeda Y. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur. J. Immunol. 2001, 31:2547-2557.
28. Lande R., Gafa V., Serafini B., Giacomini E., Visconti A., Remoli M.E., Severa M., Parmentier M., Ristori G., Salvetti M., Aloisi F., Coccia E.M. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 2008, 67:388-401.
29. Liu Z., Pelfrey C.M., Cotleur A., Lee J.C., Rudick R.A. Immunomodulatory effects of interferon beta-1a in multiple sclerosis. J. Neuroimmunol. 2001, 112:153-162.
30. Longhini A.L., von Glehn F., Brandao C.O., de Paula R.F., Pradella F., Moraes A.S., Farias A.S., Oliveira E.C., Quispe-Cabanillas J.G., Abreu C.H., Damasceno A., Damasceno B.P., Balashov K.E., Santos L.M. Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J. Neuroinflammation 2011, 8:2.
31. Lu B., Yu H., Chow C., Li B., Zheng W., Davis R.J., Flavell R.A. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 2001, 14:583-590.
32. Lu B., Ferrandino A.F., Flavell R.A. Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. Nat. Immunol. 2004, 5:38-44.
33. Mandel M., Gurevich M., Pauzner R., Kaminski N., Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 2004, 138:164-170.
34. Marie I., Svab J., Robert N., Galabru J., Hovanessian A.G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 1990, 265:18601-18607.
35. Marie I., Blanco J., Rebouillat D., Hovanessian A.G. 69-kDa and 100-kDa isoforms of interferon-induced (2'-5')oligoadenylate synthetase exhibit differential catalytic parameters. Eur. J. Biochem. 1997, 248:558-566.
36. McRae B.L., Semnani R.T., Hayes M.P., van Seventer G.A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 1998, 160:4298-4304.
37. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 2005, 115:407-417.
38. Mohan H., Krumbholz M., Sharma R., Eisele S., Junker A., Sixt M., Newcombe J., Wekerle H., Hohlfeld R., Lassmann H., Meinl E. Extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol. 2010, 20:966-975.
39. Munn D.H., Sharma M.D., Hou D., Baban B., Lee J.R., Antonia S.J., Messina J.L., Chandler P., Koni P.A., Mellor A.L. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 2004, 114:280-290.
40. Nguyen T., Liu X.K., Zhang Y., Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 2006, 176:7354-7360.
41. Noronha A., Toscas A., Jensen M.A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 1993, 46:145-153.
42. Padberg F., Feneberg W., Schmidt S., Schwarz M.J., Korschenhausen D., Greenberg B.D., Nolde T., Muller N., Trapmann H., Konig N., Moller H.J., Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 1999, 99:218-223.
43. Pertea M., Salzberg S.L. Between a chicken and a grape: estimating the number of human genes. Genome Biol. 2010, 11:206.
44. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
45. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
46. Rico M.C., Manns J.M., Driban J.B., Uknis A.B., Kunapuli S.P., Dela Cadena R.A. Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis. Transl. Res. 2008, 152:95-98.
47. Rico M.C., Rough J.J., Del Carpio-Cano F.E., Kunapuli S.P., Dela Cadena R.A. The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr. Vasc. Pharmacol. 2010, 8:338-343.
48. Ring B.Z., Ross D.T. Microarrays and molecular markers for tumor classification. Genome Biol. 2002, 3. (comment2005).
49. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
50. Rocha S., Garrett M.D., Campbell K.J., Schumm K., Perkins N.D. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 2005, 24:1157-1169.
51. Satoh J., Nakanishi M., Koike F., Miyake S., Yamamoto T., Kawai M., Kikuchi S., Nomura K., Yokoyama K., Ota K., Kanda T., Fukazawa T., Yamamura T. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 2005, 18:537-550.
52. Satoh J., Nakanishi M., Koike F., Onoue H., Aranami T., Yamamoto T., Kawai M., Kikuchi S., Nomura K., Yokoyama K., Ota K., Saito T., Ohta M., Miyake S., Kanda T., Fukazawa T., Yamamura T. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J. Neuroimmunol. 2006, 174:108-118.
53. Schultz-Cherry S., Murphy-Ullrich J.E. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J. Cell Biol. 1993, 122:923-932.
54. Schultz-Cherry S., Lawler J., Murphy-Ullrich J.E. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J. Biol. Chem. 1994, 269:26783-26788.
55. Schultz-Cherry S., Ribeiro S., Gentry L., Murphy-Ullrich J.E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 1994, 269:26775-26782.
56. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899-2912.
57. Sharief M.K., Semra Y.K., Seidi O.A., Zoukos Y. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis. J. Neuroimmunol. 2001, 120:199-207.
58. Smith I.A., Knezevic B.R., Ammann J.U., Rhodes D.A., Aw D., Palmer D.B., Mather I.H., Trowsdale J. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 2010, 184:3514-3525.
59. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 1997, 15:797-819.
60. Tanaka S., Kimura Y., Mitani A., Yamamoto G., Nishimura H., Spallek R., Singh M., Noguchi T., Yoshikai Y. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 1999, 163:5560-5565.
61. Thomas P.D., Kejariwal A., Guo N., Mi H., Campbell M.J., Muruganujan A., Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 2006, 34:W645-W650.
62. Tseveleki V., Rubio R., Vamvakas S.S., White J., Taoufik E., Petit E., Quackenbush J., Probert L. Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes. Genomics 2010, 96:82-91.
63. Vallin H., Blomberg S., Alm G.V., Cederblad B., Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 1999, 115:196-202.
64. Whartenby K.A., Calabresi P.A., McCadden E., Nguyen B., Kardian D., Wang T., Mosse C., Pardoll D.M., Small D. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16741-16746.
65. Xiao C., Chen S., Yuan M., Ding F., Yang D., Wang R., Li J., Tanguay R.M., Wu T. Expression of the 60 kDa and 71 kDa heat shock proteins and presence of antibodies against the 71 kDa heat shock protein in pediatric patients with immune thrombocytopenic purpura. BMC Blood Disord. 2004, 4:1.
66. Yamashiro H., Yoshizaki S., Tadaki T., Egawa K., Seo N. Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity. J. Leukoc. Biol. 2010, 88:757-767.
67. Yamazaki T., Goya I., Graf D., Craig S., Martin-Orozco N., Dong C. A butyrophilin family member critically inhibits T cell activation. J. Immunol. 2010, 185:5907-5914.
68. Zhou A., Hassel B.A., Silverman R.H. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 1993, 72:753-765.
69. Zou W., Machelon V., Coulomb-L'Hermin A., Borvak J., Nome F., Isaeva T., Wei S., Krzysiek R., Durand-Gasselin I., Gordon A., Pustilnik T., Curiel D.T., Galanaud P., Capron F., Emilie D., Curiel T.J. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 2001, 7:1339-1346.